<!DOCTYPE HTML>
<html>
  <head>
    <meta http-equiv="Content-type" content="text/html;" >
	<title>Methylphenidate Long Acting</title>
	</head>
  <body onLoad="init();">
    <div data-role="page" data-theme="b">
  	<div data-role="header" data-theme="b" data-position="fixed">
    	<h1>Methylphenidate Long Acting</h1> 
    	<a href="#" data-rel="back" data-icon="arrow-l" data-theme="b" data-direction="reverse" >Back</a>
	</div>
    <div data-role="content">
<h3>Brand names: Ritalin SR, LA, Concerta, Metadate CD and ER</h3>
<hr>
					<h3>Adult Starting Dose (Max Per Day)</h3>	
					<ul>
						<li>Initial stimulant dose for Metadate ER and Ritalin SR = may be given in place of immediate release products once the daily dose is titrated and the titrated 8 hour dose corresponds to the SR or ER tablet</li> 
						<li>Max dose = 60mg/day </li>
						<li>Initial stimulant dose for Metadate CD and Ritalin LA = 20mg QD </li>
						<li>Titrate in 10-20mg increments weekly </li>
						<li>Max dose = 60mg/day </li>
						<li>Initial stimulant dose for Concerta = 18mg QAM </li>
						<li>May increase in 18mg increments weekly </li>
						<li>Max dose = 72mg per day</li>
					</ul>
<hr>
					<h3>Advantages</h3>	
					<ul>
						<li>Take 30-45 minutes before a meal </li>
						<li>Take Concerta with water, milk or juice </li>
						<li>Metadate CD should be taken before breakfast </li>
						<li>Metadate ER should be taken before breakfast and lunch </li>
						<li>Metadate CD and Ritalin LA capsules may be opened and contents sprinkled on applesauce; Swallow applesauce without chewing; Do not mix with warm applesauce since the release properties  may be affected</li>
					</ul> 
<hr>
					<h3>Disadvantages</h3>	
					<ul>
						<li><b>Contraindications: includes a history of substance abuse, idiosyncratic reactions to sympathomimetic amines, marked anxiety, tension and agitation, glaucoma and family history or diagnosis of Tourette's syndrome or tics; Additional contraindications for Metadate are severe hypertension, heart failure,  arrhythmia, hyperthyroidism,thyrotoxicosis and recent MI or angina</b></li> 
						<li>Adverse Events: insomnia, decreased appetite, GI upset,  headaches, dizziness, motortics, irritability, anxiousness and tearfulness </li>
						<li>Possible addiction potential </li>
						<li>Requires additional prescription regulation under federal or state law</li> 
						<li>Cannot be refilled, only one month of therapy at a time may be prescribed</li>
						<li>Do not chew, crush or divide </li>
						<li>Use may include drug holidays to assess usefulness </li>
					</ul>
<hr>
					<h3>Pregnancy Category</h3>	
					<ul>
							<li>Risk cannot be ruled out, but potential benefits may justify potential risk</li>	
					</ul>
<hr>
					<h3>Safety Margins</h3>	
					<ul>
						<li>Methylphenidate and Modafinil contraindicated within 14 days following MAOI therapy </li>
						<li>Contraindications with Methylphenidate are halogenated anesthetics; Do not administer on the day of surgery </li>
						<li>Avoid concurrent use with alcohol </li>
						<li>Avoid concurrent use of Methylphenidate with ephedra and yohimbe</li>
					</ul>




    </div><!-- end jqm content -->
   
    </div><!-- end jqm page -->
  </body>
</html>
